An intramuscular (IM) glucocorticoid injection for reducing knee pain in patients with knee osteoarthritis in primary care could present an inferior effect to an intra-articular (IA) glucocorticoid injection at four weeks, but not after eight and 24 weeks, according to a new Dutch prospective study.
The researchers set out to study the different outcomes between the injection types knowing that some practitioners prefer administering IM over IA injections. “We also know that many general